US Stock MarketDetailed Quotes
EVFM Evofem Biosciences
- 0.017
- +0.003+17.96%
15min DelayClose Apr 26 16:00 ET
769.49KMarket Cap0.34P/E (TTM)
0.019High0.013Low555.90KVolume0.013Open0.014Pre Close8.61KTurnover1.21%Turnover Ratio0.34P/E (Static)45.94MShares3.73852wk High-0.01P/B769.43KFloat Cap0.01252wk Low--Dividend TTM45.94MShs Float23550.000Historical High--Div YieldTTM38.73%Amplitude0.012Historical Low0.015Avg Price1Lot Size
Evofem Biosciences Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 87.26%-8.97M | 97.40%-170K | 85.50%-2.36M | 94.40%-1.49M | 76.39%-4.94M | 51.99%-70.41M | 69.29%-6.53M | 56.38%-16.3M | 50.24%-26.66M | 39.29%-20.92M |
| Net income from continuing operations | 169.07%52.98M | 74.64%-2.11M | -26.26%66.01M | 93.21%-8.56M | 92.62%-2.35M | 62.62%-76.7M | 83.83%-8.34M | 220.85%89.51M | -276.89%-125.98M | 30.91%-31.89M |
| Operating gains losses | -168.89%-68.15M | -95.26%47K | -376.09%-70.16M | -97.34%1.89M | -95.00%84K | --98.92M | --991K | --25.41M | --70.84M | --1.68M |
| Depreciation and amortization | -12.95%1.78M | 3.51%1.33M | -85.20%37K | -30.80%173K | -7.55%245K | 100.00%2.05M | 349.47%1.28M | -6.72%250K | -9.09%250K | 35.90%265K |
| Other non cash items | -44.37%1.8M | -228.68%-691K | 108.16%612K | -45.52%814K | 16.45%1.07M | -20.30%3.24M | -39.12%537K | -65.97%294K | 77.65%1.49M | -38.06%918K |
| Change In working capital | -21.44%4.73M | -6.09%4.29M | -266.85%-619K | 189.12%3.85M | -151.60%-2.79M | -43.11%6.02M | -68.64%4.56M | -92.53%371K | 71.85%-4.32M | -15.68%5.41M |
| -Change in receivables | -186.64%-4.61M | -94.98%584K | 79.41%-1.12M | 176.39%2.21M | -408.80%-6.28M | 198.90%5.32M | 581.27%11.64M | -491.44%-5.46M | -1,388.66%-2.89M | 210.07%2.03M |
| -Change in inventory | 34.48%2.11M | 181.59%758K | -137.46%-357K | 129.22%1.8M | -113.11%-99K | 7,557.14%1.57M | -149.23%-929K | 16.65%953K | 175.02%787K | 145.05%755K |
| -Change in prepaid assets | 41.19%3.66M | -29.74%430K | -83.17%796K | 153.53%917K | 246.53%1.52M | -81.32%2.59M | -95.43%612K | 59.85%4.73M | 89.35%-1.71M | -107.61%-1.04M |
| -Change in payables and accrued expense | 1,154.62%4.62M | 158.49%1.77M | -126.89%-160K | 46.65%-454K | -5.18%3.46M | -93.27%368K | -211.13%-3.03M | -61.86%595K | -176.12%-851K | 5,430.30%3.65M |
| -Change in other current liabilities | -9.16%-1.48M | 95.73%-46K | -122.92%-44K | -26,466.67%-797K | -26.82%-591K | 10.15%-1.35M | -147.02%-1.08M | 144.86%192K | 99.28%-3K | -103.49%-466K |
| -Change in other working capital | 117.51%434K | 129.73%789K | 142.19%270K | -49.57%175K | -270.58%-800K | -33.15%-2.48M | -342.33%-2.65M | -165.24%-640K | -72.63%347K | 113.36%469K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 87.26%-8.97M | 97.40%-170K | 85.50%-2.36M | 94.40%-1.49M | 76.39%-4.94M | 51.99%-70.41M | 69.29%-6.53M | 56.38%-16.3M | 50.24%-26.66M | 39.29%-20.92M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 98.83%-4K | 0 | 0 | 99.41%-1K | 95.45%-3K | 87.32%-341K | 33.96%-35K | 88.27%-70K | 87.25%-170K | 90.65%-66K |
| Net PPE purchase and sale | 98.83%-4K | --0 | --0 | 99.41%-1K | 95.45%-3K | 88.40%-341K | 33.96%-35K | 88.27%-70K | 87.25%-170K | 93.10%-66K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 98.83%-4K | --0 | --0 | 99.41%-1K | 95.45%-3K | 87.32%-341K | 33.96%-35K | 88.27%-70K | 87.25%-170K | 90.65%-66K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -92.29%4.78M | -77.33%340K | -45.82%2.14M | -98.56%597K | -88.76%1.7M | -31.70%61.94M | -84.80%1.5M | 24,562.50%3.95M | -21.67%41.36M | -45.98%15.13M |
| Net issuance payments of debt | -20.01%4.49M | -85.07%224K | --2.12M | 108.45%498K | -83.60%1.64M | --5.61M | --1.5M | --0 | ---5.89M | --10M |
| Net common stock issuance | --0 | --0 | --0 | --0 | --0 | -60.38%32.3M | --0 | --0 | -49.85%26.82M | -80.46%5.48M |
| Proceeds from stock option exercised by employees | -98.85%290K | --116K | -99.67%14K | -99.53%99K | --61K | 5,433.11%25.23M | --0 | 3,799.09%4.29M | --20.94M | --0 |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | 7.32%-1.2M | --0 | -261.05%-343K | 44.96%-508K | -697.73%-351K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -92.29%4.78M | -77.33%340K | -45.82%2.14M | -98.56%597K | -88.76%1.7M | -31.70%61.94M | -84.80%1.5M | 24,562.50%3.95M | -21.67%41.36M | -45.98%15.13M |
| Net cash flow | ||||||||||
| Beginning cash position | -64.85%4.78M | -95.83%410K | -97.14%636K | -80.16%1.53M | -64.85%4.78M | -81.19%13.59M | -60.69%9.84M | -64.65%22.27M | -88.12%7.73M | -81.19%13.59M |
| Current changes in cash | 52.38%-4.2M | 103.36%170K | 98.18%-226K | -106.18%-898K | 44.64%-3.24M | 84.98%-8.81M | 55.76%-5.07M | 67.26%-12.42M | 790.45%14.53M | 18.19%-5.86M |
| End cash Position | -87.86%580K | -87.86%580K | -95.83%410K | -97.14%636K | -80.16%1.53M | -64.85%4.78M | -64.85%4.78M | -60.69%9.84M | -64.65%22.27M | -88.12%7.73M |
| Free cash flow | 87.32%-8.97M | 97.41%-170K | 85.56%-2.36M | 94.43%-1.5M | 76.45%-4.94M | 52.71%-70.75M | 69.20%-6.57M | 56.88%-16.37M | 51.14%-26.83M | 40.74%-20.99M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg